Antitumoral Agent-Induced Constipation: A Systematic Review
Background: Constipation is a common symptom in patients receiving antitumoral treatment. The mechanisms underlying antitumoral agent-induced constipation (ATAIC) are poorly defined. This systematic review aimed to analyze and synthesize the available information related to the prevalence, etiology,...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-12-01
|
| Series: | Cancers |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2072-6694/16/1/99 |
| _version_ | 1797359030498230272 |
|---|---|
| author | Agnès Calsina-Berna Jesús González-Barboteo Silvia Llorens-Torromé Joaquim Julià-Torras |
| author_facet | Agnès Calsina-Berna Jesús González-Barboteo Silvia Llorens-Torromé Joaquim Julià-Torras |
| author_sort | Agnès Calsina-Berna |
| collection | DOAJ |
| description | Background: Constipation is a common symptom in patients receiving antitumoral treatment. The mechanisms underlying antitumoral agent-induced constipation (ATAIC) are poorly defined. This systematic review aimed to analyze and synthesize the available information related to the prevalence, etiology, and treatment of ATAIC. Methods: A systematic review following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines was conducted. The review included human studies written in English, French, or Spanish involving patients with cancer and containing information about the prevalence, etiology, and treatment of ATAIC. Results: A total of 73 articles were included. The reported prevalence ranged from 0.8% to 86.6%. Six studies reported an ATAIC prevalence of over 50%. The prevalence rates of constipation of grades 3 and 4 ranged between 0 and 11%. The importance of enteric neuronal integrity in gastrointestinal function was reported. The articles with the highest levels of evidence in relation to ATAIC treatment obtained in this systematic review studied treatments with acupuncture, sweet potato, osteopath, probiotics, and moxibustion. Conclusions: The prevalence of constipation in patients undergoing antitumoral treatment is very diverse. Studies specifically designed to report the prevalence of antineoplastic treatment-induced constipation are needed. The importance of enteric neuronal integrity in gastrointestinal function was described. Thus, neuroprotection could be an area of research for the treatment of chemotherapy-induced gastrointestinal disorders. |
| first_indexed | 2024-03-08T15:10:46Z |
| format | Article |
| id | doaj.art-d4ca8a37c9ed47b6a92fa22990f0d703 |
| institution | Directory Open Access Journal |
| issn | 2072-6694 |
| language | English |
| last_indexed | 2024-03-08T15:10:46Z |
| publishDate | 2023-12-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Cancers |
| spelling | doaj.art-d4ca8a37c9ed47b6a92fa22990f0d7032024-01-10T14:52:38ZengMDPI AGCancers2072-66942023-12-011619910.3390/cancers16010099Antitumoral Agent-Induced Constipation: A Systematic ReviewAgnès Calsina-Berna0Jesús González-Barboteo1Silvia Llorens-Torromé2Joaquim Julià-Torras3Palliative Care Department, School of Medicine, The University of Vic—Central University of Catalonia (UVIC-UCC), 08500 Vic, SpainResearch and Knowledge Group in Palliative Care of Catalan Institute of Oncology (GRICOPAL), 08916 Badalona, SpainResearch and Knowledge Group in Palliative Care of Catalan Institute of Oncology (GRICOPAL), 08916 Badalona, SpainPalliative Care Department, Institut Català d’Oncologia, 08908 Badalona, SpainBackground: Constipation is a common symptom in patients receiving antitumoral treatment. The mechanisms underlying antitumoral agent-induced constipation (ATAIC) are poorly defined. This systematic review aimed to analyze and synthesize the available information related to the prevalence, etiology, and treatment of ATAIC. Methods: A systematic review following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines was conducted. The review included human studies written in English, French, or Spanish involving patients with cancer and containing information about the prevalence, etiology, and treatment of ATAIC. Results: A total of 73 articles were included. The reported prevalence ranged from 0.8% to 86.6%. Six studies reported an ATAIC prevalence of over 50%. The prevalence rates of constipation of grades 3 and 4 ranged between 0 and 11%. The importance of enteric neuronal integrity in gastrointestinal function was reported. The articles with the highest levels of evidence in relation to ATAIC treatment obtained in this systematic review studied treatments with acupuncture, sweet potato, osteopath, probiotics, and moxibustion. Conclusions: The prevalence of constipation in patients undergoing antitumoral treatment is very diverse. Studies specifically designed to report the prevalence of antineoplastic treatment-induced constipation are needed. The importance of enteric neuronal integrity in gastrointestinal function was described. Thus, neuroprotection could be an area of research for the treatment of chemotherapy-induced gastrointestinal disorders.https://www.mdpi.com/2072-6694/16/1/99neoplasmsconstipationantineoplastic agents |
| spellingShingle | Agnès Calsina-Berna Jesús González-Barboteo Silvia Llorens-Torromé Joaquim Julià-Torras Antitumoral Agent-Induced Constipation: A Systematic Review Cancers neoplasms constipation antineoplastic agents |
| title | Antitumoral Agent-Induced Constipation: A Systematic Review |
| title_full | Antitumoral Agent-Induced Constipation: A Systematic Review |
| title_fullStr | Antitumoral Agent-Induced Constipation: A Systematic Review |
| title_full_unstemmed | Antitumoral Agent-Induced Constipation: A Systematic Review |
| title_short | Antitumoral Agent-Induced Constipation: A Systematic Review |
| title_sort | antitumoral agent induced constipation a systematic review |
| topic | neoplasms constipation antineoplastic agents |
| url | https://www.mdpi.com/2072-6694/16/1/99 |
| work_keys_str_mv | AT agnescalsinaberna antitumoralagentinducedconstipationasystematicreview AT jesusgonzalezbarboteo antitumoralagentinducedconstipationasystematicreview AT silviallorenstorrome antitumoralagentinducedconstipationasystematicreview AT joaquimjuliatorras antitumoralagentinducedconstipationasystematicreview |